ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis

FRA:ABL • US0028241000

98.455 EUR
+1.61 (+1.67%)
Last: Feb 24, 2026, 09:04 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ABL. ABL was compared to 65 industry peers in the Health Care Equipment & Supplies industry. While ABL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ABL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ABL was profitable.
  • ABL had a positive operating cash flow in the past year.
  • ABL had positive earnings in each of the past 5 years.
  • ABL had a positive operating cash flow in 4 of the past 5 years.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • ABL has a better Return On Assets (16.60%) than 95.38% of its industry peers.
  • Looking at the Return On Equity, with a value of 27.43%, ABL belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
  • The Return On Invested Capital of ABL (8.88%) is better than 75.38% of its industry peers.
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROIC 8.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • ABL has a better Profit Margin (31.88%) than 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of ABL has grown nicely.
  • ABL has a better Operating Margin (18.29%) than 76.92% of its industry peers.
  • ABL's Operating Margin has improved in the last couple of years.
  • ABL has a Gross Margin of 56.19%. This is comparable to the rest of the industry: ABL outperforms 49.23% of its industry peers.
  • ABL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • ABL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for ABL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 5.38 indicates that ABL is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.38, ABL belongs to the top of the industry, outperforming 89.23% of the companies in the same industry.
  • ABL has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
  • ABL has a better Debt to FCF ratio (1.87) than 80.00% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that ABL is not too dependend on debt financing.
  • The Debt to Equity ratio of ABL (0.23) is better than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Altman-Z 5.38
ROIC/WACC0.91
WACC9.81%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • ABL has a Current Ratio of 1.70. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
  • ABL has a Current ratio (1.70) which is comparable to the rest of the industry.
  • ABL has a Quick Ratio of 1.24. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.24, ABL is in line with its industry, outperforming 56.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.24
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 10.28% over the past year.
  • The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
  • ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
  • ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.38% yearly.
  • ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 22.53, the valuation of ABL can be described as rather expensive.
  • Based on the Price/Earnings ratio, ABL is valued a bit cheaper than 67.69% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, ABL is valued at the same level.
  • The Price/Forward Earnings ratio is 20.20, which indicates a rather expensive current valuation of ABL.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
  • When comparing the Price/Forward Earnings ratio of ABL to the average of the S&P500 Index (27.75), we can say ABL is valued slightly cheaper.
Industry RankSector Rank
PE 22.53
Fwd PE 20.2
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ABL's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 29.17
EV/EBITDA 18.24
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.96
PEG (5Y)3.16
EPS Next 2Y10.76%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • ABL has a Yearly Dividend Yield of 2.25%.
  • Compared to an average industry Dividend Yield of 1.14, ABL pays a bit more dividend than its industry peers.
  • ABL's Dividend Yield is a higher than the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

  • On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 28.93% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
  • ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABBOTT LABORATORIES

FRA:ABL (2/24/2026, 9:04:52 AM)

98.455

+1.61 (+1.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap171.20B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts80
Price Target115.93 (17.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly Dividend1.88
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-7.4%
PT rev (3m)-7.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 22.53
Fwd PE 20.2
P/S 4.6
P/FCF 29.17
P/OCF 22.12
P/B 3.96
P/tB 9.43
EV/EBITDA 18.24
EPS(TTM)4.37
EY4.44%
EPS(NY)4.87
Fwd EY4.95%
FCF(TTM)3.38
FCFY3.43%
OCF(TTM)4.45
OCFY4.52%
SpS21.4
BVpS24.87
TBVpS10.44
PEG (NY)1.96
PEG (5Y)3.16
Graham Number49.45
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROCE 11.52%
ROIC 8.88%
ROICexc 9.99%
ROICexgc 19.14%
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
FCFM 15.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Debt/EBITDA 1.04
Cap/Depr 70.33%
Cap/Sales 5.02%
Interest Coverage 250
Cash Conversion 81.77%
Profit Quality 49.49%
Current Ratio 1.7
Quick Ratio 1.24
Altman-Z 5.38
F-Score8
WACC9.81%
ROIC/WACC0.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.17%
EBIT Next 3Y13.91%
EBIT Next 5Y13.17%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A

ABBOTT LABORATORIES / ABL.DE FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.


What is the profitability of ABL stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ABL stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 22.53 and the Price/Book (PB) ratio is 3.96.


How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 28.93%.